Early Evaluation of Alzheimer’s disease: Biomarkers and Neuropsychological Tests

dc.creatorLanfranco G., Renzo
dc.creatorManríquez Navarro, Paula
dc.creatorAvello G., Leyla
dc.creatorCanales Johnson, Andrés
dc.date.accessioned2016-11-11T19:29:03Z
dc.date.accessioned2022-10-17T17:54:09Z
dc.date.available2016-11-11T19:29:03Z
dc.date.available2022-10-17T17:54:09Z
dc.date.created2016-11-11T19:29:03Z
dc.date.issued2012
dc.identifierRevista Médica de Chile, 2012, vol.140, n° 9, p. 1191-1200
dc.identifierhttp://hdl.handle.net/11447/824
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4423918
dc.description.abstractAlzheimer disease is a neurodegenerative condition that affects cognitive, behavioral and global functioning of patients. Currently and due to the lack of conclusive biological testing, Alzheimer's disease diagnosis is based primarily on clinical criteria. Since its early diagnosis allows clinical interventions when neurological damage is relatively mild, the development of early detection tools has become a major topic of interest. In this article, we review the main neurobiological and neuropsychological features of Alzheimer's disease, analyzing the use of biomarkers and neuropsychological testing for early detection. (Rev Med Chile 2012; 140: 1191-1200).
dc.languageen_US
dc.subjectAlzheimer disease
dc.subjectBiological markers
dc.subjectNeurobiology
dc.subjectNeuropsychology
dc.titleEarly Evaluation of Alzheimer’s disease: Biomarkers and Neuropsychological Tests
dc.typeArtículo


Este ítem pertenece a la siguiente institución